Taiho Oncology, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 3 | |
| Phase 1/2 | 2 | |
| Phase 2 | 4 | |
| Phase 2/3 | 2 | |
| Phase 3 | 2 |
Disease areas by active trials, top 10 of 15
Acute Myeloid Leukemia (AML) (5) · Leukemia (5) · Myelodysplastic Syndromes (MDS) (4) · Lung Cancer (3) · Non-Small Cell Lung Cancer (NSCLC) (3) · Cholangiocarcinoma (2) · MDS/MPN Overlap (2) · Cervical Cancer (1) · DLBCL (1) · Esophageal Cancer (1)
Get alerts when Taiho Oncology, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.